Page 2 - Brian Goff News Today

Profund Advisors LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 23.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,116 shares of the biopharmaceutical company’s stock after selling 7,028 shares during the quarter. Profund […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report)’s stock price was up 9% during mid-day trading on Thursday . The company traded as high as $29.22 and last traded at $29.22. Approximately 362,598 shares changed hands during trading, a decline of 57% from the average daily volume of 840,643 shares. The stock had previously closed […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]

1. The pessimistic view on Ethiopia. 2. Inside the NBA’s chess club. 3. Brian Goff on education and the cost disease. 4. Genes and depression and bad luck is…

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, January 25th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of ($6.05) per share for the year, up from their previous […]

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) were up 5.2% on Thursday . The company traded as high as $23.24 and last traded at $22.62. Approximately 365,022 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 962,941 shares. The stock had previously closed at $21.51. […]

Brian Goff, CEO of Agios Pharmaceuticals Inc (NASDAQ:AGIO), executed a sale of 12,066 shares in the company on January 9, 2024, according to a recent SEC filing.